APDN Awarded Contract by HDT Bio For Rapid Vaccine Development Program
April 25th, 2024
Tag: Vaccines
Peer-Reviewed Journal Validates linearDNA™ as DNA-Based Vaccine
January 5th, 2023
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
September 30th, 2022
First Successful Administration of LinearDNA via Lipid Nanoparticles
August 10th, 2022
LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
July 25th, 2022
Beefing Up Cancer Treatments, With A Vaccine In Sight
February 18th, 2022
Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort
June 7th, 2021
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 6th, 2021
Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Felines
March 2nd, 2021